Literature DB >> 15997830

Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods.

E Nemutlu1, S Demircan, S Kir.   

Abstract

Zero and first order derivative UV spectrophotometric methods were developed for the analysis of lornoxicam (LOR). The solutions of the standards and pharmaceutical samples were prepared in 0.05 N NaOH. Absorbances of LOR were measured at 376 nm for the zero order by measuring height of peak from zero and at 281 and 302 nm for the first order derivative spectrophotometric method by measuring peak to peak height. The linearity ranges were found to be 0.5-35 microg/mL for the zero order and 0.2-75 microg/mL for the first order derivative UV spectrophotometric method. The methods were validated and applied to the determination of LOR in pharmaceutical preparations (tablet and injectable, both containing 8 mg LOR). It was concluded that the methods developed were accurate, sensitive, precise, robust, rugged and useful for the quality control of LOR in pharmaceutical preparations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15997830

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  5 in total

1.  Investigation on the micelle-sensitized Ce(IV)-lornoxicam-Rh B chemiluminescence system and its application.

Authors:  Fang Zhao; Wenhui Zhao
Journal:  J Fluoresc       Date:  2011-10-04       Impact factor: 2.217

2.  Simultaneous determination of paracetamol and lornoxicam by RP-HPLC in bulk and tablet formulation.

Authors:  Mahesh Attimarad
Journal:  Pharm Methods       Date:  2011-01

3.  Development and validation of reversed phase-high-performance liquid chromatography method for determination of paracetamol and lornoxicam in tablet dosage form.

Authors:  Deepak Kumar Jain; Pratibha Patel; H S Chandel; Abhay Kushwaha; Nilesh Jain
Journal:  Pharm Methods       Date:  2011-01

4.  A validated high-performance thin layer chromatography method for estimation of lornoxicam and paracetamol in their combined tablet dosage form.

Authors:  Sanjay L Borisagar; H U Patel; C N Patel; Ujjawal P Jayswal
Journal:  Pharm Methods       Date:  2011-04

5.  Development and validation of a HPTLC method for simultaneous estimation of lornoxicam and thiocolchicoside in combined dosage form.

Authors:  Madhusmita Sahoo; Pratima Syal; Asawaree A Hable; Rahul P Raut; Vishnu P Choudhari; Bhanudas S Kuchekar
Journal:  Pharm Methods       Date:  2011-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.